Publication | Open Access

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Medicinal ChemistryBiochemistryMedicineNovel Hydrophilic GroupsNatural SciencesGlycobiology4-Benzyl-5-isopropyl-1h-pyrazol-3-yl β-D-glycopyranosidesStructure–activity RelationshipsDrug DevelopmentPharmacologyPharmaceutical ChemistryCarbohydrate-protein InteractionDrug DiscoveryGlycosylation